Jingyi Jiang

1.2k citations
42 papers · 853 indexed · h-index 17
Topics
interferon and immune responses (8 papers)RNA modifications and cancer (8 papers)RNA Research and Splicing (8 papers)
Partner nations
ChinaSouth KoreaCanada

In The Last Decade

Jingyi Jiang

40 papers receiving 845 citations

Peers

Jingyi Jiang
Comparison fields: 5 of 102
  • Molecular Biology 546
  • Cancer Research 265
  • Immunology 157
  • Oncology 149
  • Surgery 79
Replace Lenka Kubiczková with:
Lenka Kubiczková Czechia
Davor Tomas Croatia
Andreas C. Lazaris Greece
Akimasa Hayashi Japan
Jon E. Peterson United States
Motozo Yamashita Japan
David Tacha United States
John D. Klement United States
Marco Gerling Sweden
Jingyi Jiang relative to Lenka Kubiczková Czechia Lenka Kubiczková's profile →
Citations per field
00.5×3.1×
Lenka Kubiczková · 1×
Citations per year

Countries citing papers authored by Jingyi Jiang

Since Specialization
Citations

This map shows the geographic impact of Jingyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyi Jiang more than expected).

Fields of papers citing papers by Jingyi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyi Jiang. The network helps show where Jingyi Jiang may publish in the future.

Co-authorship network of co-authors of Jingyi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jingyi Jiang. A scholar is included among the top collaborators of Jingyi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingyi Jiang. Jingyi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 7
5 6
6 14
7 29
8 112
9 24
10 28
11 13
12 8
13
The transcription factor Ikaros inhibits cell proliferation by downregulating ANXA4 expression in hepatocellular carcinoma.
19
14 10
15 27
16 31
17 56
18 38
19 8
20 19

About Jingyi Jiang

Jingyi Jiang is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 42 papers that have together received 853 indexed citations. Recurring topics across this work include interferon and immune responses (8 papers), RNA modifications and cancer (8 papers) and RNA Research and Splicing (8 papers). The work is most often cited by research in Cancer Research (265 citations), Molecular Biology (546 citations) and Immunology (157 citations). Jingyi Jiang has collaborated with scholars based in China, South Korea and Canada. Frequent co-authors include Jing Yan, Jiamei Wang, Hua‐Qin Wang, Bao-Qin Liu, Huaiyu Qiao, Xiaona Meng, Hao Liang, Chao Li, Chao Li and Chao Li. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026